First Command Advisory Services’s Novavax NVAX Stock Holding History

First Command Advisory Services’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6	Closed	-$49	–	1283
2026 Q1	$49	Buy	+6	New	+$54	﹤0.01%	1120

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

First Command Advisory Services's NVAX Position: Q2 2026 in Review

First Command Advisory Services sold out of Novavax (NVAX) in Q2 2026, closing a stake of 6 shares — an estimated $49 sold.

First Command Advisory Services first reported a position in NVAX in Q1 2026 and held it in 1 quarter. The position peaked at $49 in Q1 2026. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

First Command Advisory Services reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
First Command Advisory Services sold 6 Novavax shares in Q2 2026, an estimated $49.
First Command Advisory Services first reported a position in Novavax in Q1 2026 and held it in 1 quarter.
First Command Advisory Services's Novavax position peaked at $49 in Q1 2026.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.